95 related articles for article (PubMed ID: 18043718)
81. Familial amyotrophic lateral sclerosis and Alzheimer's disease. Transgenic models.
Wong PC; Borchelt DR; Lee MK; Pardo CA; Thinakaran G; Martin LJ; Sisodia SS; Price DL
Adv Exp Med Biol; 1998; 446():145-59. PubMed ID: 10079842
[No Abstract] [Full Text] [Related]
82. Of mice, men and motor neurons.
Newbery HJ; Abbott CM
Trends Genet; 2001 Oct; 17(10):S2-6. PubMed ID: 11585669
[TBL] [Abstract][Full Text] [Related]
83. Copper-zinc superoxide dismutase and ALS.
Valentine JS; Hart PJ; Gralla EB
Adv Exp Med Biol; 1999; 448():193-203. PubMed ID: 10079827
[No Abstract] [Full Text] [Related]
84. Redox modifier genes and pathways in amyotrophic lateral sclerosis.
Carter BJ; Anklesaria P; Choi S; Engelhardt JF
Antioxid Redox Signal; 2009 Jul; 11(7):1569-86. PubMed ID: 19187001
[TBL] [Abstract][Full Text] [Related]
85. Amyotrophic lateral sclerosis and gene therapy.
Miller TM; Smith RA; Cleveland DW
Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
[No Abstract] [Full Text] [Related]
86. Genetic aspects of amyotrophic lateral sclerosis.
Siddique T; Lalani I
Adv Neurol; 2002; 88():21-32. PubMed ID: 11908227
[No Abstract] [Full Text] [Related]
87. Amyotrophic lateral sclerosis: human challenge for neuroscience.
Rowland LP
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1251-3. PubMed ID: 7877963
[No Abstract] [Full Text] [Related]
88. [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 10. Amyotrophic lateral sclerosis].
Aoki M
Nihon Naika Gakkai Zasshi; 2013 Aug; 102(8):1978-85. PubMed ID: 24167857
[No Abstract] [Full Text] [Related]
89. A study of the dual role of copper in superoxide dismutase as antioxidant and pro-oxidant in cellular models of amyotrophic lateral sclerosis.
Carrì MT; Battistoni A; Ferri A; Gabbianelli R; Rotilio G
Adv Exp Med Biol; 1999; 448():205-13. PubMed ID: 10079828
[No Abstract] [Full Text] [Related]
90. ALS predisposition modifiers: knock NOX, who's there? SOD1 mice still are.
Valdmanis PN; Kabashi E; Dion PA; Rouleau GA
Eur J Hum Genet; 2008 Feb; 16(2):140-2. PubMed ID: 18043718
[No Abstract] [Full Text] [Related]
91. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
92. [ALS models by transgenic animals].
Aoki M; Nagai M; Kato M; Itoyama Y
No To Shinkei; 2001 Sep; 53(9):799-807. PubMed ID: 11596474
[No Abstract] [Full Text] [Related]
93. Genetics of amyotrophic lateral sclerosis.
Robberecht W
J Neurol; 2000 Dec; 247 Suppl 6():VI/2-6. PubMed ID: 19714405
[TBL] [Abstract][Full Text] [Related]
94. Amyotrophic lateral sclerosis as a complex genetic disease.
Simpson CL; Al-Chalabi A
Biochim Biophys Acta; 2006; 1762(11-12):973-85. PubMed ID: 16973338
[TBL] [Abstract][Full Text] [Related]
95. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis.
Valentine JS; Doucette PA; Zittin Potter S
Annu Rev Biochem; 2005; 74():563-93. PubMed ID: 15952898
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
